TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a newly designed bioactive coating aimed at optimizing the interaction between titanium orthopaedic implants and bone tissue. The coating incorporates calcium phosphate derived from hydroxyapatite along with nitrogen compounds linked to nitric oxide synthesis. Laboratory experiments revealed that human mesenchymal stem cells exhibited significantly improved viability on surfaces treated with this coating compared to uncoated titanium. The researchers analyzed the coating’s structure, chemical makeup, mechanical attributes, and biological responses. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists created the experimental layers through reactive magnetron sputtering of a hydroxyapatite target inside a vacuum chamber. They manipulated the nitrogen-to-argon ratio during the deposition process to observe how each mixture influenced the surface characteristics. The study tested five different conditions, from pure nitrogen to pure argon, measuring parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests evaluated the biological response of human cells to the modified titanium surfaces.
Results indicated that the argon concentration impacted several physical features of the coatings. Surfaces formed in pure argon proved denser and harder than those produced in pure nitrogen. As the proportion of argon increased, so did the coating’s thickness. Chemical analysis revealed the presence of nitrogen-carbon and nitrogen-oxygen bonds on the coated surfaces. The study then compared the behavior of human mesenchymal stem cells grown on coated titanium with those on uncoated samples. The biological assessments focused on cell viability and markers associated with osteogenic differentiation.
Enhanced Cell Survival Demonstrated in Coating Tests
According to the research data, cells exhibited notably higher survival rates on coated surfaces compared to uncoated titanium. After a period of seven days, coatings with increased nitrogen content also appeared to suppress activity in certain genes linked to early bone cell differentiation. Despite these genetic changes, the cells maintained their capacity for bone formation. The experiments were conducted under controlled laboratory conditions using human mesenchymal stem cells and did not involve testing in patients or assessing the clinical efficacy of implanted devices.
The biomedical evaluation was carried out by specialists from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from researchers at Saint Petersburg State University. Funding for the project was provided through Russia’s national science program. The team aimed to identify gas mixtures that could produce coatings with optimal physical, chemical, and biological properties. Hydroxyapatite is already used in implant coatings because its calcium phosphate structure closely resembles the mineral component found in human bone.
Research Still in Laboratory Phase
The scientists plan to extend their investigations beyond the initial seven-day cell experiments. Future studies will examine stem cell behavior over 10 to 28 days, evaluate how rapidly the coatings dissolve, and measure nitric oxide release into surrounding tissues in living organisms. These additional tests were not part of the current published results, which focused on in vitro responses of coated titanium substrates and their physical and chemical properties, rather than clinical outcomes for orthopaedic patients.
The data obtained offers in-depth insights into how varying nitrogen and argon ratios influence calcium phosphate coatings applied to titanium. The researchers documented differences in coating thickness, density, hardness, chemical bonding, and cellular response across the tested gas mixtures. Results also showed that coated samples supported higher stem-cell survival than bare titanium under laboratory conditions. Nonetheless, the study remains preclinical, and the experiments published do not establish safety or efficacy in human patients. Additional biological testing will be necessary to explore properties not addressed in this initial research.